Live Breaking News & Updates on Marie Godar

Patients taking efgartigimod, a drug being studied for use to treat chronic primary immune thrombocytopenia (ITP), exhibited a significantly greater improvement in platelet counts which are essential to clotting and stopping bleeding, compared to those taking a placebo, according to results reported from the ADVANCE IV clinical trial, which was conducted globally, including at Georgetown University Medical Center. ....

New York , United States , France General , United Kingdom , City Of , Yoshitaka Miyakawa , Marc Michel , Francesco Rodeghiero , Davidj Kuter , Adrianc Newland , Monica Carpenedo , Emily Henderson , Catherine Broome , Vickie Mcdonald , Marie Godar , Jamesb Bussel , Jaume Ayguasanosa , Haematology Project Foundation , Medstar Georgetown University Hospital , Georgetown University Medical Center , Henri Mondor University Hospital , Department Of Haematology , National Reference Center , Saitama Medical University Hospital , London School Of Medicine Dentistry , American Society Of Hematology ,